donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AZN AstraZeneca > Detailed Quotes

AZN AstraZeneca

66.900
+2.450+3.80%
Close 06/24 16:00 ET
66.90000.00%
Post Mkt Price 06/24 17:41 ET
High
66.930
Open
66.460
Turnover
375.76M
Low
65.750
Pre Close
64.450
Volume
5.64M
Market Cap
207.31B
P/E(TTM)
Loss
52wk High
71.700
Shares
3.10B
P/E(Static)
1672.50
52wk Low
52.757
Float Cap
206.70B
Bid/Ask %
73.91%
Historical High
71.700
Shs Float
3.09B
Volume Ratio
0.82
Historical Low
5.645
Dividend TTM
1.435
Div Yield TTM
2400
P/B
5.70
Dividend LFY
2.14%
Div Yield LFY
3587.44%
Turnover Ratio
0.18%
Amplitude
1.83%
Avg Price
66.584
Lot Size
1
Float Cap
206.70B
Bid/Ask %
73.91%
Historical High
71.700
Shs Float
3.09B
Volume Ratio
0.82
Historical Low
5.645
Dividend TTM
1.435
P/B
5.70
Dividend LFY
2.14%
Turnover Ratio
0.18%
Amplitude
1.83%
Avg Price
66.584
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company’s marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
CEO: Soriot M.B.A., Pascal
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...